2024 alcohol and substance use disorders research program meeting, programmatic, administrative and scientific support services

Ended Awarded Last action

Contract number
HT942524F0196
Awardee
Awarding agency
Obligated
$64,185

Award facts

Opportunity
Contract value 59% obligated
$109,529.06 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00003 · Support services for the alcohol and substance use disorders research program, congressionally directed medical research programs -$45,344
Terminate for Convenience P00002 · Congressionally directed medical research programs (RP) alcohol and substance use disorders RP for service members and their families, veterans and the american… $0
Supplemental Agreement for work within scope P00001 · Alcohol and substance use disorders research program, congressionally directed medical research programs $0
Original award $109,529

About this award

Leidos, Inc., through its Services Operating Segment (doing business as SAIC), received a delivery order award valued at approximately $109.5K from the Defense Health Agency on August 31, 2024, to provide programmatic, administrative, and scientific support services for the 2024 Alcohol and Substance Use Disorders Research Program Meeting under the Congressionally Directed Medical Research Programs (CDMRP). This cost-plus-fixed-fee contract will be performed in Frederick, Maryland, with an ultimate completion date of August 30, 2025. No small business set-aside designation was applied to this award.

The CDMRP, managed by the Defense Health Agency, funds high-impact medical research in areas of significant concern to the military and public health. Under this delivery order, Leidos will support the operational and scientific aspects of the alcohol and substance use disorders research program meeting, providing the administrative infrastructure and technical expertise necessary to facilitate the program's research initiatives and collaborative activities. This award represents a continuation of Leidos' extensive portfolio of medical research support services across federal agencies, building on the company's established capabilities in delivering comprehensive research program management and support services.

Quick answers

Who was awarded contract HT942524F0196?

HT942524F0196 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on August 31, 2024.

How much is contract HT942524F0196 worth?

The government has obligated $64,185 on HT942524F0196. Its current value, with exercised options, is $109,529.

Is contract HT942524F0196 an order under another contract?

Yes. HT942524F0196 is a delivery order under HT942523D0002, an indefinite delivery contract.

Was contract HT942524F0196 competed?

The extent of competition for HT942524F0196 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award